Legend Biotech LEGN
NASDAQ LEGN
$19.32 -0.57 (-2.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Legend Biotech (LEGN) posted Liabilities and Shareholders Equity of $1.75 billion for Q2 2026, up 3.6% from $1.69 billion a year earlier and up 9.7% from the prior quarter.

Analysis

Legend Biotech (LEGN) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Legend Biotech's Liabilities and Shareholders Equity came in at $1.73 billion, up 3.8% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
  • In prior years, Legend Biotech's Liabilities and Shareholders Equity was $1.67 billion in FY2024 (-9.7%), $1.85 billion in FY2023 (+38.9%), $1.33 billion in FY2022 (+18.9%) and $1.12 billion in FY2021 (+55.0%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity since Q2 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in two of the last eight quarters, with an average decline of 3.2%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2022, with growth of 69.1%; the weakest was Q4 2024, with a decline of 9.7%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $1.6 billion (Q1 2026), $1.73 billion (Q4 2025) and $1.71 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Legend Biotech 3.67 Bn -74.25 Mn 251.50 Mn 1.75 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Bn
Mar 31, 2026 1.60 Bn
Dec 31, 2025 1.73 Bn
Sep 30, 2025 1.71 Bn
Jun 30, 2025 1.69 Bn
Mar 31, 2025 1.62 Bn
Dec 31, 2024 1.67 Bn
Sep 30, 2024 1.74 Bn
Jun 30, 2024 1.80 Bn
Mar 31, 2024 1.78 Bn
Dec 31, 2023 1.85 Bn
Sep 30, 2023 1.84 Bn
Jun 30, 2023 1.93 Bn
Mar 31, 2023 1.21 Bn
Dec 31, 2022 1.33 Bn
Mar 31, 2022 1.04 Bn
Dec 31, 2021 1.12 Bn
Sep 30, 2021 813.77 Mn
Jun 30, 2021 875.13 Mn
Mar 31, 2021 615.25 Mn
API Access

Legend Biotech Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LEGN&period=max&api_key=YOUR_API_KEY